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Signaling networks respond to diverse stimuli, but
how the state of the signaling network is relayed to
downstream cellular responses is unclear. We mod-
eled how incremental activation of signaling mole-
cules is transmitted to control apoptosis as a function
of signal strength and dynamic range. A linear rela-
tionship between signal input and response output,
with the dynamic range of signaling molecules
uniformly distributed across activation states, most
accurately predicted cellular responses. When nonli-
nearized signals with compressed dynamic range
relay network activation to apoptosis, we observe
catastrophic, stimulus-specific prediction failures.
We develop a general computational technique,
‘‘model-breakpoint analysis,’’ to analyze the mecha-
nism of these failures, identifying new time- and stim-
ulus-specific roles forAkt, ERK,andMK2kinaseactiv-
ity in apoptosis, which were experimentally verified.
Dynamic range is rarely measured in signal-transduc-
tion studies, but our experiments using model-break-
point analysis suggest itmaybeagreaterdeterminant
of cell fate than measured signal strength.
INTRODUCTION
Changes in cell behavior are determined by an interconnected
set of proteins that actively transmit signaling information as
a network (Irish et al., 2004; Jordan et al., 2000; Pawson, 2004).
Modifications of the posttranslational state, enzymatic activity,
or total level of key proteins can act as ‘‘molecular signals’’
that are relayed and interpreted to control cell function. The chal-
lenge of identifying which observed molecular signals determine
a cell response is complicated because many signaling proteins
appear to send mixed or opposing messages. For example, the
transcription factor nuclear factor-kB (NF-kB) is widely regarded
as a prosurvival protein because nuclear relocalization and DNAbinding upregulate expression of apoptosis inhibitors such as
c-IAP2, Bcl-xL, and c-FLIP (Karin and Lin, 2002). In response
to DNA-damaging agents, however, nuclear NF-kB can promote
cell death by recruiting histone deacetylases that silence antia-
poptotic genes (Campbell et al., 2004). Molecular signals can
not only change their phenotypic meaning but also the relative
importance of their message. Tumor cells, for instance, become
addicted to chronically activated mitogenic pathways that are
used only transiently in normal cells (Weinstein, 2002). Tools
that could predict or explain such context-specific roles of mo-
lecular signals would be valuable for designing better-targeted
therapies against disease (Blume-Jensen and Hunter, 2001;
Miller-Jensen et al., 2007).
Many data-driven approaches exist for grouping, separating,
or predicting outcomes on the basis of complex quantitative pat-
terns of signaling or gene expression (D’Haeseleer, 2005; Janes
and Yaffe, 2006; Noble, 2006). The problem with all of them is
that they cannot distinguish molecules that are mechanistically
linked to a phenotype from biomarkers that are correlative but
not causative (Sawyers, 2008). This difficulty can be avoided
by creating models from data sets that consist of molecular
signals with recognized but complicated roles in the outcome
that is to be predicted (Janes et al., 2005; Miller-Jensen et al.,
2007). The drawback is that one’s interpretation of such a model
is biased toward the recognized roles of the molecular signals
and away from more-surprising correlations with phenotype
that could indicate new mechanisms. Data-driven models often
identify hundreds of correlations in large data sets, making it
impractical to perturb each one experimentally. Thus, an addi-
tional means for filtering correlation-based hypotheses is greatly
needed.
Here, we develop a general approach, called ‘‘model-break-
point analysis,’’ which involves globally perturbing the measure-
ments used to build a data-drivenmodel and then quantifying the
loss of model accuracy. We altered signaling-network measure-
mentsbymanipulating eachmolecular signal’s ‘‘dynamic range,’’
defined as the responsiveness of cell outcomes to incremental
changes in signal activation. Dynamic range has been under-
studied, because signaling networks are typicallymeasured in ei-
ther their basal (minimum) or hyperstimulated (maximum) statesCell 135, 343–354, October 17, 2008 ª2008 Elsevier Inc. 343
Figure 1. The TNF-EGF-Insulin Apoptotic-Signaling Network
(A) Classic overview of the TNF-EGF-insulin network. Mechanistically connected activating signals are represented by arrows, and inhibitory signals are shown by
barred lines. Nodes corresponding to proteins whose activities we directly measured are shown as red ovals.
(B) Systems overview of the TNF-EGF-insulin apoptotic-signaling network. Dashed lines indicate the autocrine cascade activated by TNF (Janes et al., 2006). The
two perturbations of the TGF-a and IL-1a autocrine feedback circuits (by C225 and IL-1ra, respectively) are highlighted in red. Intracellular signals (rectangles) are
divided into groups (purple, orange, blue, green) on the basis of linked statistical dependencies identified by a data-driven model. A stress-apoptosis group
(orange) and a cell-survival group (green) contribute heavily to two molecular basis axes, defined by the first two principal components of the model, which
together accurately predict apoptosis induced by TNF, EGF, and insulin (Janes et al., 2005). A subset of time-dependent signals from these groups, indicated
by yellow dots, form the largest contributors to the molecular basis axes of the network.(Irish et al., 2004; Janes et al., 2004; Natarajan et al., 2006; Wolf-
Yadlin et al., 2006). This is despite the fact that intermediate
network states, induced by subsaturating stimuli, are more likely
to be experienced physiologically.
Using two independent data-driven models (Janes et al., 2005;
Kumar et al., 2007), we found, surprisingly, that perturbing dy-
namic range did not cause progressive declines in model accu-
racy. Rather, model predictions remained highly accurate until
reaching a defined ‘‘breakpoint,’’ where they failed catastrophi-
cally. Only a few molecular signals and stimuli turn out to be
responsible for failed predictions at the breakpoint. This allowed
us to reveal new, context-specific roles for molecular signals
that were not prominent in the originalmodels but were confirmed
to be critical regulators nonetheless. In addition, our analysis sug-
gested that a linear and uniform dynamic range of molecular sig-
nals is agenerally important requirement for thecontrol of cell phe-
notypes,whichwedirectly demonstrate for the stress kinaseMK2
on the basis of a data-drivenmodel of cytokine-inducedcell death
(Janes et al., 2005).We show that stimulus-dependent MK2 cata-
lytic activity appears to have been optimized for dynamic range
rather than signal strength to maximize the apoptotic response
of cells to a diverse range of cytokines. Contrary to conventional
thinking,we thereforeconclude that thedynamic rangeoverwhich
signalingoccurs isagreater determinant of cellularoutcomes than
either thebasalormaximally induciblesignalstrength.Asageneral
approach, model-breakpoint analysis is useful for extracting new
biological mechanisms from large data sets and for identifying
general principles about how signal-transduction networks trans-
mit information to mediate downstream responses.344 Cell 135, 343–354, October 17, 2008 ª2008 Elsevier Inc.RESULTS
We started to explore how specific molecular signals control
phenotypic outcomes by using a data-driven model of cyto-
kine-induced apoptosis (Janes et al., 2005). This model is based
on a data set of 7980measurements ofmolecular signals that are
dynamically activated by combinations of tumor necrosis factor
(TNF), which is a death stimulus, together with either epidermal
growth factor (EGF) or insulin, which are survival stimuli (Janes
et al., 2006) (see the Supplemental Data available online). Most
proteins whose activities and levels were measured were caus-
ally implicated in cytokine signaling or apoptosis (Figure 1A), but
how collective information from these pathways determines
a cell’s decision to die or survive was unclear.
After measuring the extent of cell death experimentally, we
examined how the measured molecular signals could function
together to control apoptosis by using partial least-squares
regression (Janes and Yaffe, 2006). This method combines
a large number of experimentally measured signaling events
(‘‘variables’’ composed of time-derived signaling metrics; see
the Supplemental Data) into a smaller number of super-variables
called principal components that are trained to predict cell-death
outcomes. The resulting data-driven model accurately captures
the apoptotic responses induced by various TNF-EGF-insulin
combinations (Janes et al., 2005), as measured by a ‘‘fitness
function’’ that quantifies the predictive ability of the model
(Gaudet et al., 2005) (see the Supplemental Data).
Themodel also led us to recognize two previously unknown au-
tocrine feedback loops involving transforming growth factor a
Figure 2. Selective Failure of Nonlinear Models Linking Signal
Activation to Signal Output for Predicting Apoptosis
(A) The saturation model with k = 2, 0.8, and 0.2 compared to the original linear
model (Linear response, gray line). Signal output was amplified at low levels of
signal activation and saturated at moderate to high levels of signal activation.
For all k values, the minimum (Min) and maximum (Max) observed values for
each signaling metric were preserved.
(B) Predictions of apoptosis after perturbation of the TGF-a autocrine feed-
back circuit with C225, or the IL-1a feedback loop with IL-1ra, in models
with increasing saturation compared to the original linear model. The accuracy
of predictions was quantified bymodel ‘‘fitness,’’ where a value of 1 is a perfect
match between predicted andmeasured values. A specific data point boxed in
yellow is further expanded in (C) as an example. The model breakpoint is
indicated where catastrophic failure of the C225 prediction occurs.
(C) An example of good model fitness. Measured and predicted apoptosis are
shown for the 12 apoptotic readouts corresponding to the TNF+IL-1ra condi-
tion and a saturatedmodel with k = 0.3, highlighted in (B). Perfect model fitness
(= 1) is shown in green as a reference.
(D) The desensitization model with k = 2, 0.8, and 0.2 compared to the original
linear model (Linear response, gray line). Signal output was attenuated relative
to true measured signal activation, particularly at low-to-moderate levels of
activation. For all k values, the minimum (Min) and maximum (Max) observed
values for each signaling metric were preserved.
(E) Predictions of apoptosis after perturbation of the TGF-a autocrine feedback
loop with C225, or the IL-1a feedback loop with IL-1ra, in models with increas-
ing desensitization compared to the original linear model. Model fitnesses
quantifying the agreement between prediction and experiment were calcu-(TGF-a) and interleukin-1a (IL-1a) (Janes et al., 2006). Secretion of
both of these cytokines was induced by TNF, and their autocrine
stimulationplayedkey roles inmodulating the subsequent apopto-
tic response (Figure 1B). Importantly, the model accurately pre-
dicted the profound effects onTNF-induced signaling andapopto-
sis that resulted from blocking TGF-a (with the anti-receptor
antibodyC225)or IL-1a (with the receptorantagonist IL-1ra) (Janes
et al., 2005), despite the fact that neither of these autocrine factors
is explicitly specified in thedata set. Thus, the accurate predictions
of cell death after autocrine blockade are a stringent and indepen-
dent validation of the model’s general predictive ability.
Perturbing Dynamic Range Reveals Context-Specific
Model Breakpoints
To examine how signaling activity influenced cell death, we ma-
nipulated the dynamic range of the measured signals computa-
tionally. We used mathematical functions that, when multiplied
by the original data set, maintained the minimum and maximum
experimentally determined values of signaling activity but
dampened or amplified the intermediate values hyperbolically
on the basis of a single nonlinearity parameter (Figures 2A
and 2D; see the Experimental Procedures). As the nonlinearity
parameter (k) decreases, the effective dynamic range of each
signaling molecule becomes compressed. We first investigated
models where the signal output increased rapidly at low signal-
ing and saturated at high signaling (Figure 2A). Saturation could
occur biologically if, for example, the availability of a down-
stream effector were to become limiting when signal activation
is high. As the nonlinearity parameter k was progressively
decreased, the models showed a small gradual decline in their
ability to predict apoptosis after TGF-a blockade with C225,
followed by an abrupt drop in model performance when k = 0.8
(Figure 2B). Notably, predictive accuracy did not simply erode
away with increasing saturation. Instead, the models tolerated
some degree of saturation before reaching a catastrophic
‘‘breakpoint,’’ where the accuracy fell dramatically. Surpris-
ingly, this failure was specific to disruption of the TGF-a auto-
crine circuit; predictions of apoptosis induced by TNF with or
without IL-1a blockade were unaffected (Figures 2B and 2C,
Figure S1A, and data not shown; see the Supplemental Data).
This suggested that perturbing dynamic range causes nonglo-
bal failures within a data-driven model that are treatment
specific and thus context specific.
lated as in (B). A specific data point boxed in yellow is further expanded in
(F) as an example. The model breakpoint is indicated where catastrophic
failure of the IL-1ra prediction occurs.
(F) An example of no prediction (n.p.). Measured and predicted apoptosis
are shown for the 12 apoptotic readouts corresponding to the TNF+IL-1ra con-
dition and a desensitized model with k = 0.2, highlighted in (E). Perfect model
fitness (= 1) is shown in green as a reference.
For (B) and (E), model fitness is shown as the R2 value ± 90% Fisher Z-trans-
formed confidence intervals for the regression model: Measured apoptosis =
Predicted apoptosis (see the Experimental Procedures). For (C) and (F) data
are shown as the central prediction ± crossvalidated standard error (SE) along
the x axis and themean ± standard error of the mean (SEM) of triplicate biolog-
ical measurements along the y axis. Apoptosis data are from four readouts
measured by flow cytometry at three time points (Janes et al., 2005).Cell 135, 343–354, October 17, 2008 ª2008 Elsevier Inc. 345
We next looked at desensitization. A reaction pathway could
appear to be desensitized if, for example, multimerization of
the activator were required for signal transmission to down-
stream effectors. A desensitization function was defined that
warped the activation-output relationship similarly to the satura-
tion function but in the opposite direction (Figure 2D; see the Ex-
perimental Procedures). Models with increasing desensitization
again showed drastically different accuracies in predicting the
apoptotic response (Figure 2E). Here, the TGF-a perturbation
and training-data predictions were completely accurate across
all desensitization values, but now the quality of the apoptosis
predictions after IL-1ra blockade dropped precipitously when
k was below 0.8 (Figures 2E and 2F, Figure S1B, and data not
shown). Once again, the models reached a sudden ‘‘breakpoint’’
where small changes in dynamic range caused a complete loss
of predictive accuracy, suggesting that the models could
accommodate a finite amount of desensitization in themolecular
signals before failing. Therefore, saturation and desensitization
complement one another in their ability to reveal context-specific
breakpoints in data-driven models (see the Supplemental Data).
Similar model breakpoints were observed with other types of
data transformations (Figure S2) as well as with nonbiological
data sets (Figure S3), indicating that context-specific model
breakpoints are a general property of data-driven models.
Model-Breakpoint Analysis Identifies a TGF-a-Specific
Role for Early PI3K-Akt Pathway in TNF-Induced
Apoptosis
We sought to determine exactly whichmeasurements in the data
set caused the TGF-a blockade predictions to fail during satura-
tion and the IL-1a blockade predictions to fail during desensitiza-
tion. We reasoned that this ‘‘model-breakpoint analysis’’ could
provide context-specific insight into the function of signaling
networks. Our first application of model-breakpoint analysis re-
vealed a time- and treatment-specific role for the survival kinase
Akt (see below).
We started by examining the structure of the failed saturation
model when it had passed just beyond the breakpoint for accu-
rately predicting the TGF-a perturbation (k = 0.8). The starting
model required three principal components for optimal accuracy
(Figure 3A). Saturating the model did not affect the number of
components until the breakpoint was reached, when suddenly
the third principal component was no longer statistically informa-
tive (Figure 3B and data not shown). If the failed saturationmodel
was forced to contain three principal components, the resulting
model now accurately predicted the TGF-a perturbation (Fig-
ure 3C). Conversely, when the third principal component was
removed from the original model, prediction accuracy for
TGF-a blockade decreased substantially. Together, the model
results indicated that the third principal component was critical
for quantitatively accurate predictionswhenautocrine TGF-a sig-
naling was blocked with C225.
The importance of the third principal component was surpris-
ing because it provided only a small improvement in overall
predictive power toward the training set inwhich noTGF-ablock-
ade was performed (Figure 3A). Nevertheless, the sensitivity of
the apoptosis predictions to inclusion of the third principal com-
ponent suggested that some subtle-yet-critical information was346 Cell 135, 343–354, October 17, 2008 ª2008 Elsevier Inc.being encoded, prompting us to look at its role in greater detail.
When the third principal component was included, and the pre-
dictive accuracy of the saturation model was restored, we found
that early measurements of Akt phosphorylation became more
heavily weighted (Figure 3D). Therefore, model-breakpoint
analysis of the saturation model led us to predict that early Akt
signaling might be a critical signal for TNF-induced apoptosis
when the TGF-a autocrine circuit is disrupted.
To test the context-specific role of early PI3K-Akt signaling, we
performed timed-inhibitor experiments with LY294002, a revers-
ible inhibitor of PI3K (Figures 3E and 3F). After TNF stimulation of
C225-inhibited HT-29 cells, we observed strong phosphoryla-
tion of Akt at 15 min, which was blocked with LY294002 as
expected (Figure 3F). In the absence of TGF-a blockade by
C225, there was no change in apoptosis when LY294002 was
present for the first 3–4 hr after TNF stimulation and then re-
moved from themedium (Figure 3E, conditions 1 and 2), confirm-
ing earlier findings that early Akt signaling does not affect apo-
ptosis induced by TNF alone (Janes et al., 2003). Strikingly,
when PI3K-Akt was inhibited at early times in C225-treated cells,
we observed an 2-fold increase in TNF-induced apoptosis
compared to C225-treated cells in the absence of LY294002
(p < 104, conditions 3 and 4). These experiments show that
early PI3K-Akt signaling makes an important antiapoptotic
contribution only when cells lack a functional TGF-a autocrine
circuit. Therefore, by deemphasizing early Akt measurements
through loss of a principal component, the breakpoint of the
saturation model had correctly revealed a context-specific role
of early Akt signaling in promoting cell survival.
Model-Breakpoint Analysis Correctly Distinguishes
Essential Signals and a New Mechanism
for TNF-Induced IL-1a Signaling and Apoptosis
Autocrine IL-1a is a potent prodeath stimulus downstream of
TNF (Janes et al., 2006), but the relevant intracellular pathways
upstream of IL-1a release or downstream of the IL-1 receptor
that mediate this response are not known. We therefore per-
formed model-breakpoint analysis on the desensitization model
at the IL-1ra breakpoint (Figure 2E) to identify candidate regula-
tors of IL-1a-mediated apoptosis. In contrast to the saturation
breakpoint involving disruption of the TGF-a autocrine feedback
circuit, we observed no change in the number of principal com-
ponents at the model breakpoint for IL-1ra treatment (data not
shown). This prompted us to search for changes within the
principal components themselves.
Each principal component consists of weighting factors,
called ‘‘loadings,’’ that quantify how much each signaling metric
contributes to that principal component (Janes and Yaffe, 2006;
Martens and Martens, 2001). Signaling metrics with large posi-
tive or negative loading values are very important for the principal
component; conversely, molecular signals with loadings near
zero play a negligible role. At the desensitization breakpoint,
we found that some metrics decreased their weightings and
thus became ‘‘underloaded,’’ whereas others increased their
weightings and became ‘‘overloaded.’’ For prediction of apopto-
sis after autocrine IL-1a perturbation, we found that the under-
loaded metrics were critical for model performance and were
therefore likely to be of high biological importance (Figures
Figure 3. Failure of the Saturation Models Involves Loss of a Principal Component Containing Information from Early Akt Signaling
(A and B) Box-and-whisker plots showing the increase in information captured for the original linear model (A) and the saturation model (B) as the number of
principal components is increased from one principal component to four. The midline indicates the median crossvalidated variance captured across the 12
apoptotic outputs measured, the boxes indicate the 25th and 75th percentiles, and the error bars indicate the 10th and 90th percentiles. Significant increases
in variance captured were assessed by a one-sided sign-rank test. Principal components that were included in the predictive model are shown in black, and
principal components that were omitted are shown in gray.
(C) Changes inmodel fitness for the C225 prediction as the number of components for the saturation and linearmodels is changed from two principal components
(gray) to three principal components (black). Model fitness is shown as R2 value ± 90% Fisher Z-transformed confidence intervals for the regression model:
measured apoptosis = predicted apoptosis (see the Experimental Procedures).
(D) Akt signaling makes an important contribution to the third principal component when a two-component saturationmodel fails to predict apoptosis after TGF-a
blockade. The statistical significance of the overrepresentation of any particular signal in the top 30 metrics after inclusion of the third principal component was
examined by the binomial test (after correcting for multiple-hypothesis testing, a significance level [‘‘Cutoff’’] below 0.005 was required). Molecular signals are
considered overrepresented when significantly more metrics are observed in a list than would be expected by chance. See Table S1 for a complete list of
molecular signals that contribute to the third principal component.
(E) Early inhibition of Akt phosphorylation affects TNF-induced apoptosis only in the context of TGF-a blockade by C225. HT-29 cells were pretreated for 1 hr with
10 mg/ml C225 in the presence or absence of 20 mM LY294002 where indicated and then stimulated with 5 ng/ml TNF for 24 hr. At 3 hr after TNF stimulation,
LY294002 was washed out by replacement of the medium with conditioned medium from TNF+C225-treated cells. Apoptosis was measured by cleaved cas-
pase-3 staining and flow cytometry (Janes et al., 2005). Data are shown as themean ±SEMof triplicate biological measurements. The baseline apoptosis induced
by mock stimulation ± SEM (gray line) is indicated.
(F) Early TNF+C225-induced Akt phosphorylation is inhibited by LY294002. HT-29 cells were pretreated for 1 hr with 10 mg/ml C225 in the presence or absence of
20 mM LY294002 where indicated. Cells were then stimulated with 5 ng/ml TNF, and Akt phosphorylation (P-Akt) was measured 15 min later by western blotting
with b-actin as a loading control.S4A and S4B, see below). In contrast, overloaded metrics were
uninformative and thus possibly dispensable for apoptosis
induced by IL-1a and TNF (Figures S4C and S4D).
Among the top 30 overloadedmetrics in the failed desensitiza-
tion model, we found that ERK activity was significantly overrep-
resented (Figures 4A and 4B). The ERK pathway is widely
regarded as prosurvival (Ballif and Blenis, 2001) (Figure 1A),
but our analysis suggested that ERK signaling played a minimal
role in promoting survival when autocrine IL-1awas blockedwith
IL-1ra (Figure 4A). To test the importance of ERK by experiment,
we treated HT-29 cells with TNF+IL-1ra in the presence or ab-
sence of the MEK inhibitor, U0126. Despite complete inhibition
of inducible ERK phosphorylation (Figure 4C), apoptosis medi-
ated by TNF+IL-1ra was unchanged in the presence of U0126(Figure 4D), indicating that ERK plays a negligible prosurvival
role. Therefore, model-breakpoint analysis had correctly sepa-
rated an ERK-activation epiphenomenon (Figure 4C) from the
signals that actually control apoptosis (Figure 1B).
We next examined the most-underloaded metrics, which were
the direct cause of the desensitization breakpoint (Figure S4A).
When model failure occurred, we found several measurements of
MK2activity amongmetricswith the largest reduction in total load-
ings (Figures 5A and 5B). To investigate the potential role of MK2
experimentally, we perturbed MK2 signaling by modestly overex-
pressing a kinase-dead MK2 that acts as a dominant negative
(see Figure 6 below). Compared to cells expressing wild-type
MK2 at similar levels, kinase-dead MK2 showed significantly de-
creased apoptosis in response to TNF (p < 106, Figure 5C).Cell 135, 343–354, October 17, 2008 ª2008 Elsevier Inc. 347
Figure 4. Overloaded Signaling Metrics High-
light Irrelevant Signaling Information from
ERK Activity
(A) ERK activity is significantly overrepresented among
overloaded molecular signals in the desensitization
model at the point of IL-1ra-prediction failure. Statisti-
cal significance of overrepresentation in the top 30
metrics was assessed as described in Figure 3D.
(B) Overloading of ERK activity metrics contributes to
failure of the desensitization model to predict apopto-
sis after IL-1a blockade at the breakpoint (indicated
in Figure 2E). All ERK activity metrics in the top 30met-
rics with the largest positive change are shown, along
with the top five metrics that are not derived from
ERK activity. Overall rank is shown to the right of the
metric description. Changes in total loadings are
depicted by sparklines (Tufte, 2006) bounded by the
range of the data. The value at which the apoptosis
prediction by IL-1ra first fails is highlighted in red.
(C) TNF+IL-1ra induces ERK phosphorylation, which is
inhibitedbyU0126.HT-29 cellswerepretreated for 1hr
with 25mMU0126where indicated and then stimulated
with 100 ng/ml TNF + 30 mg/ml IL-1ra for 15 min. ERK
phosphorylation (P-ERK) was measured by western
blotting with total ERK levels used as a loading control.
(D) Inhibition of ERK activity by U0126 pretreatment
does not affect TNF+IL-1ra-induced apoptosis.
HT-29 cells were pretreated for 1 hr with 25 mM
U0126 where indicated and then stimulated with
100 ng/ml TNF + 30 mg/ml IL-1ra for 24 hr. Apoptosis was measured by cleaved caspase-3 staining and flow cytometry (Janes et al., 2005). Data are shown as
the mean ± SEM of triplicate biological measurements. The baseline apoptosis induced by mock stimulation ± SEM (gray line) is indicated.Importantly, the difference in TNF-induced apoptotic responses
between cells expressing kinase-dead versus wild-typeMK2 van-
ishedwhen the IL-1a autocrine circuit was blocked by IL-1ra. Sim-
ilar resultswere obtainedwith shRNA-mediated knockdown of en-
dogenousMK2 in thesecells (Figure 5DandFigureS5). Thesedata
indicate that functional MK2 signaling is quantitatively essential for
normal apoptotic regulation via TNF-induced IL-1a signaling.
Paradoxically, in the original model built on linear data, MK2
signaling contributes to TNF-induced apoptosis at early times,
whereas signaling through the IL-1a feedback loop is not
observed until somewhat later times (Janes et al., 2005, 2006).
These observations raised the possibility that MK2 could be act-
ing as a mediator that links TNF signaling to the IL-1a feedback
loop. Early TNF-induced MK2 activation was unaffected by IL-
1ra blockade (p = 0.2, Figure S6), suggesting that MK2 functions
downstream of TNF but upstream of IL-1a.
TNF induces the transcription of many proinflammatory cyto-
kines, including the IL1A gene, via activation of IKK/NF-kB
(Figure 1A) (Mori and Prager, 1996). TNF also activates the p38-
MK2 pathway, where a major role of MK2 is to stabilize AU-rich
element (ARE)-containingmRNA transcripts that are ordinarily de-
graded rapidly after transcription (Kotlyarovet al., 1999).Wenoted
that the 30 UTR of IL1A contains two copies of an UUAUUUA(U/A)
(U/A) consensus sequence implicated in destabilizing ARE-con-
taining transcripts (Lagnado et al., 1994). We therefore hypothe-
sized that earlyMK2signalingcouldbeprovidingan IL-1a-specific
proapoptotic signal by stabilizing IL1A transcripts and thereby al-
lowing sustained IL-1aproteinexpression for subsequent release.
To test this prediction, we measured IL1A mRNA levels after
treatment of cells with TNF for 1 hr, a time when MK2 remains348 Cell 135, 343–354, October 17, 2008 ª2008 Elsevier Inc.strongly activated but IKK/NF-kB signaling has returned to basal
levels (Janes et al., 2006) (Figure S6). In cells expressing wild-
typeMK2, IL1A transcript levels remainedhigh 1 hr after TNF treat-
ment (Figure5E). Incontrast, IL1A levels in cells expressingkinase-
dead MK2 had returned to baseline at 1 hr after TNF treatment.
Thus, theproapoptotic role of earlyMK2signaling appears to func-
tion throughstabilizationof IL1A transcripts, therebyamplifying the
magnitude of the prodeath IL-1a autocrine circuit induced by TNF.
Model-Breakpoint Analysis Applies to Other
Large-Scale Measurements of Signal Transduction
To test its general applicability,weappliedmodel-breakpoint anal-
ysis to a second data set of quantitative phosphoproteomic mea-
surements that had been paired with phenotypic readouts of cell
migration and proliferation in a mammary epithelial cell line (Wolf-
Yadlin et al., 2006). In this study, 62 tyrosine-phosphorylated pep-
tides were quantified at four time points shortly after stimulation of
cells with EGF or the EGF-family ligand, heregulin. A data-driven
model built on this 62-phosphopeptide signature was previously
shown tocapture themigratory andproliferative responsesof cells
stimulated with EGF or heregulin (Kumar et al., 2007). The starting
model also correctly predicts the EGF- and heregulin-induced re-
sponses of cells engineered to express 20-fold higher levels of
the EGF receptor family member, ErbB2. The treatments involving
ErbB2-overexpressing cells were not included in the initial model
and therefore serve as an independent validation of its accuracy.
We observed a clear breakpoint for predicting the effects
of ErbB2 overexpression when the phosphoproteomic data was
desensitized (Figures S7A and S7B). At this breakpoint (k = 0.2),
there was a significant enrichment in three phosphopeptides,
Figure 5. Failure of the Desensitization Model in the Context of IL-1a Blockade Occurs by Neglecting Critical Information from MK2
(A) MK2 activity is significantly underloaded in the desensitization model at the point of IL-1ra-prediction failure. Statistical significance of molecular signals that
become underloaded in the desensitization model immediately after the breakpoint was assessed as described in Figure 3D.
(B) All MK2 activity metrics in the top 30metrics with the largest negative change at the point of model failure are shown, along with the top fivemetrics that are not
derived fromMK2 activity. Overall rank is shown to the right of the metric description. Changes in total loadings are depicted by sparklines (Tufte, 2006) bounded
by the range of the data. The value at which the apoptosis prediction by IL-1ra first fails is highlighted in red.
(C and D) MK2 signaling is important for IL-1a-dependent responses to TNF. Changes in TNF- and TNF+IL-1ra-induced apoptosis are shown for HT-29 cells
overexpressing wild-type or kinase-dead MK2 (C). Changes in TNF- and TNF+IL-1ra-induced apoptosis are shown for HT-29 cells stably expressing an shRNA
for MK2 (shMK2) or control hairpin (shLuc) (D). HT-29 cells were stimulated with 100 ng/ml TNF + 30 mg/ml IL-1ra for 24 hr, and apoptosis was measured by
cleaved caspase-3 staining and flow cytometry (Janes et al., 2005). Data are shown as the mean ± SEM of sextuplicate or quadruplicate biological measure-
ments. Note that loss of MK2 signaling decreases apoptosis only when the IL-1a feedback loop is present.
(E)MK2 signaling promotes sustained expression of IL1A. HT-29 cells were stimulated with 100 ng/ml TNF for 1 hr, and IL1AmRNA levelsmeasured byRT-qPCR.
Data are shown as the mean ± SEM of triplicate biological measurements.which became undervalued in the model’s principal components
(Figure S7C). Two of these phosphopeptideswere in the scaffold-
ing protein p130Cas (Y234 and Y249), which is an important medi-
ator ofmigrationdownstreamof focal adhesion kinase (FAK) (Cary
et al., 1998). The other phosphopeptide lies in the activation loop
of ERK2 (T185Y187), which is widely known to be an important
regulator of the G1/S transition (Torii et al., 2006) and is also in-
volved in migration of epithelial cells (Matsubayashi et al., 2004).
Both ERK and p130Cas have been identified as critical signaling
proteins for mediating ErbB2-induced cell invasion of mammary
adenocarinoma cells (Spencer et al., 2000). Taking these data
together,weconclude thatmodel-breakpoint analysis is a general
tool that can derive unique biological insight from data-driven
models that link signal transduction to cell phenotype.
MK2Dynamic Range Is More Important for TNF-Induced
Apoptosis Than Absolute Signal Strength
Maximum dynamic range was clearly essential for optimum
model performance, but could dynamic range be similarly impor-tant for the function of individual signaling pathways within cells?
We focused onMK2 catalytic activity as a prototypical molecular
signal because it had emerged as an important regulator of TNF-
induced apoptosis through autocrine IL-1a (Figure 5). We first
confirmed that MK2 activation was occurring uniformly in the
entire cell population by using flow cytometry to analyze phos-
phorylation of its substrate, Hsp27 (P-Hsp27) (Stokoe et al.,
1992). P-Hsp27 increased proportionally with TNF dose (Fig-
ure 6A), allowing us to use biochemical measurements of
P-Hsp27 as an estimate of MK2 activity in vivo.
The dynamic range of MK2 signaling was experimentally
perturbed by the establishment of stable lines of HT-29 cells
expressing comparably low levels of wild-type, kinase-dead, or
constitutively active MK2 (Figure 6B). Quantitative immunoblot-
ting for P-Hsp27 showed that all cell lines displayed the expected
hyperbolic increases in MK2 activity with TNF dose (Figure 6C
and Figure S8). Compared to the responsiveness of cells overex-
pressingwild-typeMK2, however, the kinase-dead and constitu-
tively activemutants showed compressed dynamic range similarCell 135, 343–354, October 17, 2008 ª2008 Elsevier Inc. 349
Figure 6. Prediction and Experiment Indicate that Wild-Type MK2 Signaling Provides an Optimum Dynamic Range for TNF-Induced
Apoptosis
(A) Flow-cytometry profiles of HT-29 cells stimulated with the indicated TNF concentrations for 30min and stained for P-Hsp27 levels showing a dose-dependent
shift of the entire cell population, indicative of a uniform increase in MK2 activity.
(B) Overexpression of wild-type, kinase-dead, and constitutively active MK2 in HT-29 cells, which represent multiplicative, desensitized, and saturated model
variants. Cells were transduced with retroviral vectors containing the indicated MK2 constructs, and MK2 overexpression was quantified by western blotting
and densitometry compared to vector control cells. b-actin was used as a loading control.
(C) HT-29 cells stably overexpressing wild-type, kinase-dead, and constitutively active MK2 were stimulated with the indicated TNF concentrations for 30 min,
and P-Hsp27 was measured by western blotting. b-actin was used as a loading control.
(D) Densitometry quantifying relative P-Hsp27 levels in theMK2 retrovirally transduced cells after TNF stimulation as a function of P-Hsp27measured for the same
TNF concentration in wild-type MK2-overexpressing cells. Data are shown as the mean ± SEM of triplicate biological measurements.
(E) Comparison of measured and predicted apoptosis for HT-29 cells overexpressing wild-type MK2. Predictions closely matched experiments at high cytokine
concentrations.
(F) Predicted apoptosis for HT-29 cells overexpressing wild-type, kinase-dead, and constitutively active MK2 at high cytokine concentrations. Wild-type predic-
tions are replotted from (E) for comparison.
(G) Measured apoptosis for HT-29 cells overexpressing wild-type, kinase-dead, and constitutively active MK2 at high cytokine concentrations. Wild-type
measurements are replotted from (E) for comparison.
For (E) and (F), predictions are shown as the central prediction ± range of eight (E) or five (F) crossvalidation runs. For (E) and (G), HT-29 cells were stimulated with
the indicated cytokine combinations for 24 hr, and apoptosis was measured by cleaved casapase-3 staining and flow cytometry (Janes et al., 2005). Data are
shown as the mean ± SEM of triplicate biological measurements. Note that expression of either the kinase-dead or the constitutively active MK2 causes
decreased apoptosis compared to expression of wild-type MK2.to the desensitization and saturation functions used in model-
breakpoint analysis (Figure 6D, compare with Figures 2A and
2D). Thus, these MK2-overexpressing cells act as in vivo surro-
gates of linear (wild-type), desensitized (kinase dead), and satu-
rated (constitutively active) signaling via the MK2 pathway.
We first assessedwhether themodel could capture the behav-
ior of cells overexpressing wild-type MK2 at 2.2-fold above
endogenous levels (Figure 6B). The overexpression was explic-
itly incorporated into the original linear model (in which MK2
was not overexpressed) by multiplication of the preexisting cyto-
kine-stimulated MK2 time courses by 2.2. This simple approxi-
mation for proportional MK2 activation accurately captured the
extent of apoptosis observed for all six combinations of high-
dose TNF, EGF, and insulin (Figure 6E, conditions 1–6).We found350 Cell 135, 343–354, October 17, 2008 ª2008 Elsevier Inc.that themodel could not capture the extent of apoptosis induced
by low-dose concentrations of TNF (conditions 7–9), likely be-
cause of a shift in TNF sensitivity. Specifically, overexpression
of wild-type MK2 caused low-dose TNF treatments to induce
apoptosis similarly to high-dose treatments (compare conditions
2 and 9, 4 and 7, and 6 and 8 in Figure 6E). We therefore exam-
ined the kinase-dead and constitutively active MK2mutants only
under high-dose TNF conditions, where the model accurately
captured the apoptotic responses.
To model the kinase-dead and constitutively active MK2 mu-
tants, we first quantified the overexpression of each MK2 variant
(Figure 6B) and then applied the saturation and desensitization
functions with k equal to 0.2 (Figures 2A and 2D) to mimic the
activation profile of constitutively active and kinase-dead MK2,
respectively (Figures 6C and 6D). Last, for bothMK2mutants, we
challenged the model to predict how cytokine-induced apopto-
sis would be changed relative to wild-type-MK2 overexpression.
Surprisingly, the model predicted that both kinase-dead and
constitutively active MK2 would decrease TNF-induced apopto-
sis relative to the wild-type (Figure 6F). When apoptosis was
measured experimentally, we found that the two MK2 mutants
were significantly more resistant to TNF-induced apoptosis
than the wild-type (p < 0.05, Figure 6G), exactly as predicted
by the model. Thus, both model and experiment support the
nonintuitive conclusion that catalytic activity does not monoton-
ically predict how MK2 influences cell death stimulated by TNF.
Our application of model-breakpoint analysis to apoptotic
signaling indicates that the network exists in a state of ‘‘optimal
tuning’’ for signal transfer, which is achieved by maximizing the
dynamic range of molecular signals rather than interpreting
absolute signal strength.
DISCUSSION
Here, we describe a new method for quantitative analysis of the
link between signaling events and cellular responses. The tech-
nique starts with a data-driven model based on quantitative
signaling measurements that are used by the model to predict
cellular responses. The signaling data set is progressively nonli-
nearized, and the model is then rebuilt from the nonlinear data
set. Eventually, the nonlinearization reaches a critical breakpoint
where the model abruptly stops predicting cellular responses
accurately. At this breakpoint, the reason for model failure is di-
agnosed by identification of which nonlinearized signals caused
the failedmodel to be built incorrectly. The biological importance
of these specific signals is then tested by experiment for their
role in controlling the predicted cellular response. Together,
model-breakpoint analysis can identify new mechanisms that
would not have otherwise emerged from the data. Using
model-breakpoint analysis, we further propose here that the
control of cell phenotypes requires maximum dynamic range of
the response-determining pathways within the cell.
The Value of Model-Breakpoint Analysis
Many ‘‘systems-biology’’ initiatives are actively compiling large-
scale signaling measurements, and data-driven modeling is
emerging as the first level of analysis for these data sets (Gaudet
et al., 2005; Janes et al., 2005; Natarajan et al., 2006; Pradervand
et al., 2006). Model breakpoints provide a next level of analysis
by evaluating both the model performance as well as the data
upon which it was based. One practical benefit of the nonlinea-
rizations is that they gauge the sensitivity of the model predic-
tions to experiments that are not quantitative. The saturated
and desensitized relationships used to explore signal transmis-
sion could just as easily be used to simulate nonlinear assay
readouts for the measured molecular signals. Our biochemical
assays were painstakingly validated to be linear, quantitative,
and reproducible (Gaudet et al., 2005; Janes et al., 2003). In ret-
rospect, this optimization was crucial because onlyminor nonlin-
earities in the data would have been sufficient to cause failed
predictions of one or both of the autocrine perturbations. The
results here explicitly indicate that the success of data-drivenmodeling is directly tied to the quality of the large-scale mea-
surements (Janes and Yaffe, 2006). Model-breakpoint analysis
is applicable to any quantifiable set of assays and can be used
to benchmark their accuracy and consistency to help steer
data-collection efforts. As large-scale signaling experiments
are being pursued with increasing frequency (Albeck et al.,
2006), it will be important to determine the extent of quantitative
accuracy needed to analyze these data correctly. Indeed, apply-
ing model-breakpoint analysis to a phosphoproteomic data set
revealed several important phosphopeptides that were not
emphasized in the authors’ preliminary and follow-up analyses
(Kumar et al., 2007; Wolf-Yadlin et al., 2006).
Second, we found that by examining where data manipula-
tions cause sudden breakpoints in model accuracy, we can
uncover unexpected, context-specific biological connections
between individual molecular signals and apoptosis. For exam-
ple, model-breakpoint analysis correctly showed that ERK sig-
naling is not important in the prevention of TNF-induced apopto-
sis when autocrine IL-1a is blocked (Figure 7A), despite the fact
that ERK activity is among the most informative molecular
signals for predicting apoptosis overall (Janes et al., 2005). Con-
versely, early Akt signaling does not normally send an effective
antiapoptotic message when cells are treated with TNF alone
(Janes et al., 2003, 2005), but Akt emerges as a prominent
apoptosis-determining signal when these same cells are treated
with TNF and autocrine TGF-a is blocked (Figure 7B).
Part of the reason why context specificity is so puzzling is that
it is has been challenging to find experimental conditions where
such behavior can be easily revealed (Natarajan et al., 2006).
Model-breakpoint analysis provides a tool for computationally
interrogating context specificity without having to resort to
brute-force screening of ligands and inhibitors. Obviously, the
breakpoints of a data-driven model can only analyze the con-
texts of the stimulus conditions that are being predicted. We
did not, for example, rediscover the context-specific, prodeath
role of the IKK/NF-kB pathway (Campbell et al., 2004), despite
having measured it, because we lacked treatment conditions in
the data set that involved DNA damage. This stresses the impor-
tance of proper experimental design when the goal is to build
data-driven models that help reveal new biological mechanisms.
Dynamic Range in Signaling and Disease
One surprising result from this study was the prediction and ex-
perimental verification that MK2 dynamic range is more critical
for proapoptotic signaling than signal strength (Figures 7C and
7D). Retrospectively, the behavior of the different MK2 variants
could be explained from the perspective of signal transmission.
Unlike the predictions of TGF-a and IL-1a perturbation, which
selectively required low or high levels of signal activation, our
results indicate that theMK2 pathway uses its complete dynamic
range. Overexpression of a dominant-negative MK2 acts as
a buffer for signal transmission, desensitizing the pathway
such that only very strong activation events lead to productive
output from the endogenous MK2. Conversely, a constitutively
activated MK2 that has been stably incorporated provides
a tonic, near-saturating level of signaling, which reduces the
relative responsiveness of the endogenous MK2 to external
stimuli. Only overexpression of the wild-type kinase, whichCell 135, 343–354, October 17, 2008 ª2008 Elsevier Inc. 351
Figure 7. Context-Specific and Network-Level Mechanisms Revealed by Model-Breakpoint Analysis
(A) MEK-ERK signaling is not involved in TNF-induced apoptosis.
(B) Early Akt activity sends a prosurvival signal when TNF-induced TGF-a autocrine signaling is blocked. An unknown activator of early Akt (‘‘?’’) must be critical
for the prosurvival function.
(C) Wild-type MK2 signaling promotes TNF-induced apoptosis by stabilizing the autocrine IL-1a circuit.
(D) The dynamic range of MK2 is more predictive of its apoptotic contribution than MK2 signal strength. Upper left: Apoptosis induced by 5 ng/ml TNF is plotted
against MK2 signal strength asmeasured by P-Hsp27 in Figure 6C. Apoptosis increases then decreases with signal strength (green curve). Lower right: Apoptosis
induced by 5 ng/ml TNF is plotted against MK2 dynamic range as defined by the range of signal strengths where the slope of activation compared to wild-type
MK2 is greater than or equal to 1 in Figure 6D. Apoptosis appears to increase proportionally with dynamic range (green curve). Diseasemutations (red) may cause
perturbations in dynamic range that fall between the wild-type and the hyperactive-hypoactive alleles. Data are shown as the mean ± SEM of triplicate biological
measurements.both augments signal strength and maintains appropriate con-
trol of catalytic activity, maximizes the proapoptotic contribution
of MK2 to TNF-induced signaling (Figure 7D and Figure S9).
Recent work has indicated that the fold change in activity of
a signaling molecule (relative to its basal activity) is a greater de-
terminant of cell-fate control than the absolute level of signaling
(Miller-Jensen et al., 2006; Sasagawa et al., 2005). Because fold
changes in activation are a direct reflection of the dynamic range
in which phenotypic information is communicated, these data
independently support our conclusions. Indeed, the reduction
of effective dynamic range is our main explanation for the de-
crease in cytokine-induced apoptosis that we observed when
cells express constitutively active MK2, a kinase whose function
is mainly proapoptotic (Kotlyarov et al., 1999).
To test the predicted effect of nonlinear MK2 signaling, we
chose to stably overexpress constitutively active or kinase-
dead MK2 mutants and compare their behavior to that of wild-352 Cell 135, 343–354, October 17, 2008 ª2008 Elsevier Inc.typeMK2.We have found that suchmutation-based approaches
are more effective at nonlinearizing signal activation-output
relationships than other techniques. RNA interference (RNAi) or
wild-type overexpression, for instance, reduce or increase the in-
duced level of signaling but do not affect the general linearity of
dynamic range as a function of these levels (Figure S9). Discrep-
ancies between RNAi- and dominant-negative-based perturba-
tions of a signaling pathway have not been openly documented.
However, we predict that differences should arise occasionally
because these approaches affect dynamic range differently.
For example, in our work, the small but significant increase in
TNF+IL-1ra-induced apoptosis in cells overexpressing kinase-
dead MK2 (Figure 5C) was not observed when MK2 levels were
downregulated with an RNA hairpin (Figure 5D). An important
function of MK2 is to stabilize AU-rich transcripts (Winzen et al.,
1999), suggesting that dynamic rangemay be particularly impor-
tant at the interface between signaling and gene expression.
Although complete gain- and loss-of-functionmutations cause
dramatic changes in signaling responsiveness, more subtle
amino-acid changes (single-nucleotide polymorphisms, disease
mutations, etc.) could alter dynamic range with pathophysiolog-
ical consequences (Figure 7D).Our finding that cellular outcomes
are highly sensitive to dynamic range suggests that mutant pro-
teins should be characterized under conditions that capture
a breadth of activation states. This is perhaps best achieved by
induction of the networkwith diverse stimuli in a dose-dependent
and combinatorial manner (Figure 6).
In general, computational models aremost valuable when they
provide new biological insight that can then be verified experi-
mentally. Model-breakpoint analysis is a newmethod for hypoth-
esis generation using prevalidated models. Model breakpoints
are not mere computational anomalies but instead highlight
previously unexplored aspects of a data-driven model that are
biologically relevant. Just as it is no longer possible to compre-
hend signal-transduction networks by intuition alone (Jordan
et al., 2000), we believe that models of networks cannot be fully
grasped by mere inspection of their parameters or their predic-
tions. Our study using model-breakpoint analysis suggests that
dynamic range may be a particularly important criterion for the
evolution of complex signaling networks.
EXPERIMENTAL PROCEDURES
See the Supplemental Data for a detailed description of standard experimental
procedures and reagents.
Data-Driven Modeling
The signal-response data sets and partial least-squares models of cytokine-
induced apoptosis and EGF-heregulin-induced migration-proliferation have
been described elsewhere (Janes et al., 2005; Janes et al., 2006; Kumar
et al., 2007; Wolf-Yadlin et al., 2006). Additional details are available in the
Supplemental Data.
Partial Least-Squares Modeling and Model Fitness
Application of partial least-squares to biological data has been described in
detail elsewhere (Janes et al., 2004; Janes and Yaffe, 2006). Before all analy-
ses, the signaling and apoptosis matrices were variance scaled to nondimen-
sionalize the different measurements. Model predictions were made via cross-
validation by leaving out one of the observations, and model uncertainties
were calculated by jack-knifing (Efron and Tibshirani, 1993). So that the accu-
racy of predictions could be assessed, model fitness (R2) was calculated
according to the following formula (Gaudet et al., 2005):
R2 = 1
2
6666664
Pn
i = 1
ðPredictedi MeasurediÞ2
Pn
i = 1
ðPredictediÞ2 
Pn
i =1
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2
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3
7777775
;
where Predictedi is the prediction of the i
th apoptotic output, Measuredi is the
measurement of the ith apoptotic output, and n is the total number of apoptotic
outputs. An R2 value of 1 indicates a perfect match between measured (x) and
predicted (y) apoptosis values. As the R2 value drops to zero and below, the
comparison is better fit by the equation y = 0 than y = x. Ninety percent confi-
dence intervals for model fitness were calculated by the Fisher inversion.
Model-Breakpoint Analysis
All model-breakpoint analyses were performed on the apoptosis model after
a 60 subspace rotationof thefirst twoprincipal components tomaintainconsis-tencywith earlier studies (Janes et al., 2005). Derivationof the saturationandde-
sensitization functions is available in the Supplemental Results and Discussion.
For assessment of relative variable importance, the information content of each
signalingmetric was assessed by its variable importance in the projection (VIP):
VIPk =
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
K
PA
a= 1
w2akSSa
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a= 1
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vuuuuuut ;
where K is the total number of signaling metrics, wak is the weight of the k
th
metric for principal component a, A is the total number of principal compo-
nents, and SSa is the sum of squares explained by principal component
a (Wold, 1994). The change in total loadings between models a and b (Dpa,b)
was calculated according to the following formula:
Dpa;b =
Xm
i =1

pb;i  pa;i

;
where pa,i and pb,i are the scores for the i
th principal component of models
a and b, and m is the total number of principal components. Signaling metrics
were ranked by their largest positive and negative changes in total loadings,
and the significance for each molecular signal among the top 30 metrics
was assessed by the binomial test after the Bonferroni correction to adjust
for multiple-hypothesis testing.
MK2 Predictions
Forwild-typeMK2predictions, themeasuredMK2 signaling time courseswere
multiplied by the fold overexpression (Figure 6B). MK2-signaling metrics were
then re-extracted and input into the original linear model as test observations.
For prediction of the MK2 mutants, an overexpression model was explicitly
trained with measured apoptosis values for the wild-typeMK2-overexpressing
cells stimulated with saturating cytokines (Figure 6E, conditions 1–6). Mutant
MK2 time courses were approximated by multiplying by the corresponding
fold overexpression (Figure 6B), re-extractingmetrics, andmultiplying themet-
rics by the saturation or desensitization functions with k = 0.2. Similar results to
Figure 6F were obtained when nonlinear functions were applied with k = 0.8
(data not shown).
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Results and Discussion, Supplemen-
tal ExperimentalProcedures,elevenfigures,andone tableandcanbe foundwith
this article online at http://www.cell.com/cgi/content/full/135/2/343/DC1/.
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